Insurers will not cover obesity meds set to cost users €2,500-plus a year
As a result, it will be available only on private prescription at a cost of €215 or more a month. That equates to an annual ...
pharmaphorum20h
High-dose semaglutide ramps up weight loss, says Novo
Shares in Novo Nordisk fell sharply after the announcement. However, that was likely driven by news that Wegovy and two other semaglutide products – Ozempic and Rybelsus for type 2 diabetes ...